# LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE

> **NCT04141046** · NA · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 4 (actual)

## Conditions studied

- Systemic Lupus Erythematosus
- Depression

## Interventions

- **DEVICE:** XCSITE100 Stimulator - Individualized theta-tACS
- **DEVICE:** XCSITE100 Stimulator - Individualized alpha-tACS
- **DEVICE:** XCSITE100 Stimulator - Active Sham

## Key facts

- **NCT ID:** NCT04141046
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-01
- **Primary completion:** 2023-07-12
- **Final completion:** 2023-09-15
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Terminated due to end of funding period.
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04141046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04141046, "LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04141046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*